We present a case of hepatocellular carcinoma (HCC) in the placenta of healthy baboon (Papio spp.). Grossly, the fetal, maternal, and placental tissues were unremarkable. Histologically, the placenta contained an unencapsulated, poorly demarcated, infiltrative, solidly cellular neoplasm composed of cells that resembled hepatocytes.
| INTRODUC TI ON
Hepatocellular carcinoma (HCC) is the sixth most prevalent form of cancer, the most common liver malignancy and the second most common cause of death from cancer worldwide. 1, 2 The increase in frequency of HCC has been associated with the rise of non-alcoholic fatty liver disease (NAFLD) through activation of glutamine synthetase. 3 Extrahepatic locations of primary and secondary HCC are rare and include abdominal and thoracic wall, diaphragm, 4 and metastases in different organs. 5,6,7 While hepatocellular carcinoma is common, finding this type of cancer within the placenta is a rare occurrence in humans with only few cases reported worldwide. [8] [9] [10] [11] [12] [13] [14] [15] There are no cases of primary placental HCC reported in non-human primates. Here, we describe the incidental finding of a hepatocellular carcinoma in the placenta of a baboon (Papio spp.). A 16- year-old, captive born female baboon (Papio spp) had a history of one stillbirth and six live births (total of seven offspring during an 8 year reproductive period). Placental histopathology from the previous stillbirth was not remarkable. The animal was enrolled into an IACUC approved protocol after completing a health check and received high-fat diet at least 6 months prior to and throughout pregnancy. The pregnancy was not remarkable. All biochemical and CBC parameters were within the normal limits for this species during pregnancy. A cesarean section was performed close to term (165 days of gestation) according to the experimental protocol; maternal weight prior to conception was 21.99 kg, which is above the | 69
| DE SCRIP TION

| Animal's characteristics
SCHLABRITZ-LOUTSEVITCH ET AL.
normal published range for female baboons. 16, 17 Fetal (female fetus) and placental weights were 709.32 g and 186.4 g, respectively, which is within the published range for this species. 16 The gross appearance of fetal and maternal hepatic tissues was unremarkable at necropsy. Microscopic evaluation showed that the fetal liver had diffuse marked hepatocyte glycogenosis (normal in a fetus). The maternal liver was also unremarkable microscopically.
| Tissue fixation
Specimens were fixed in 10% neutral buffered formalin, processed conventionally, embedded in paraffin, cut at 5 micrometers, stained with hematoxylin and eosin and evaluated by both a board-certified veterinary pathologist and human perinatal pathologist.
Histology: The placenta contained an unencapsulated, poorly demarcated neoplasm that infiltrated into the villous tissue, cell islands, and placental septa. The neoplastic cells were arranged in a generally solid pattern, supported by scant to inapparent fibrovascular stroma and inconspicuous intra-tumoral capillaries. The neoplastic cells resembled hepatocytes, with some loss of cohesiveness, vesicular nuclei with open reticular chromatin, occasionally slightly irregular contours, distinct nucleoli and a mitotic rate up to 2 per 10 high power fields ( Figure 1A) . Focally, the cells had a spindle cell pattern ( Figure 1B ). There was a focal necrosis and hemorrhage. No bile production or pale bodies were observed.
| Immunohistochemistry
Immunohistochemistry was performed on tissue samples collected from the placenta with antibodies listed in Table 1 Figure 1H ). The tumor was ER-negative; vascular markers (CD31 and D240), S100, glypican, C-reactive protein, FABP, desmin, and beta-catenin were also negative (Table 1, Figure 1 , Figure S1 ). The cross reactivity of the antibodies with the baboon tissues has been published for the majority of used antibodies (Table 1) and intact placental tissue from the same specimen was used as an internal control ( Figure S1 ).
| D ISCUSS I ON
To our knowledge, this is the first report of primary HCC in a nonhuman primate placenta. Baboons have been extensively described as a model of obesity 17, 59, 60 in which a high-fat diet induces a phenotype similar to humans, including atherosclerosis 61 and NAFLD. 62 However, very few cases of primary liver cancer have been described in this species. 63, 64 In the case presented here, the animal was on a high-fat diet for 6 months prior to and during pregnancy.
Interestingly, maternal dietary quality is positively correlated with glutamine synthetase expression. 65 Association between high-fat diet and HCC is underlined by the fact that glutamine synthetase is the part of the central mechanism of obesity-induced NAFLD to 
Immuno-reactivity in human HCC cases and in NHP tissues
Immuno-reactivity in the present case and antibodies' information a CAM 5.2 (Low molecular weight cytokeratin: 7 and 8)
Marker for cells of epithelial origin, 18 HCC transformation. Glutamine synthetase is an early marker of HCC 50 and was positive in this case. Another protein, influenced by maternal high-fat diet, is a Fatty Acid Binding Protein -1 (FABP-1). In the rodent model of maternal HFD, liver expression of FABP1 was decreased in male offspring. 66 In general, FABP1 plays critical roles in tumor initiation and progression in several types of cancer. FABP1 expression is down-regulated in cell lines and tissues in HCC, and decreased expression of FABP1 correlates with lower survival rates and a higher tumor recurrence through a mechanism of increased aerobic glycolysis. 67 In line with these observations, FABP was negative in the presented case, which is also in agreement with the recent reports about the association of HCC with lack of FABP-1 staining. 44 Another marker of HCC is Arginase -1 68 with high expression in well-differentiated tumors. This enzyme is expressed in the cytoplasm and nucleus and is responsible for hydrolyses of arginine in the urea cycle. 69 Integrase interactor 1 (Ini-1), part of the pathway of chromatin remodeling in cancer, 46, 47 was strongly positive in the present case. CD10 has been reported within the battery of tissue markers, used to confirm a diagnosis of HCC. 69, 70 The tumor was ER-negative, indicating hormonal independence. The cases of hepatic neoplasia described in human placenta 12, 13 are benign lesions-hepatocellular adenomas (HA).
It has been suggested that these neoplasms arise from displaced yolk sac elements with hepatocytic differentiation. 12 In the presented case, low molecular weight cytokeratin (CAM 5.2) antibody staining was negative, pointing out earlier origin of the neoplasm, since CAM 5.2 is a marker of mature hepatocytes. 71 which have been shown to promote metastasis and tumor growth in HCC. 32 Based on immunophenotype (positive Arginase-1), the HCC in the described case can be called "conventional" as opposed to the fibrolamellar type (FL-HCC) 72, 73 termed primary HCC.
FL-HCC is characterized by the presence of well-differentiated tumor cells, organized in cords, separated by fibrous lamellae, 74 and comprises 1%-9% of HCCs, affecting younger adults as compared to conventional HCC, which affects an older population. [75] [76] [77] However, the lack of clinical associations, for example presence of the chronic liver injury, typically seen in patients with conventional HCC and the lack of positivity of other markers of conventional HCC, suggest the possibility of a unique, not yet described HCC type in this case. Antibodies, used in the study References 
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